Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type

International Journal of Cancer

Volumn 79, Issue 1, 1998, Pages 91-95

  Akslen, Lars A ^a,b   Monstad, Sissel E ^a   Larsen, Benedikte ^a   Straume, Oddbjørn ^a   Øgreid, Dagfinn ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DNA BINDING;

ADULT; AGED; FEMALE; GENES, P53; HUMANS; MALE; MELANOMA; MIDDLE AGED; POINT MUTATION; PROGNOSIS; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032549042     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980220)79:1<91::AID-IJC17>3.0.CO;2-K     Document Type: Article

References (30)

1. AAS, T., BØRRESEN, A.-L., GEISLER, S., SMITH-SØRENSEN, B., JOHNSEN, H., VARHAUG, I.E., AKSLEN, L.A., and LØNNING, P.E., Specific p53 gene mutations are associated with de novo resistance to doxorubicin therapy in patients with breast cancer. Nature (Med.), 2, 811-814 (1996).
2. AKSLEN, L.A. and MØRKVE, O., Expression of p53 protein in cutaneous melanoma. Int. J. Cancer, 52, 13-16 (1992).
3. BRASH, D.E., RUDOLPH, J.A., SIMON, J.A., MCKENNA, G.J., BADEN, H.P., HALPERIN, A.J. and PONTÉN, J., A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. nat. Acad. Sci. (Wash.), 88, 10124-10128 (1991).
4. CASTRESANA, J.S., RUBIO, M.-P., VASQUES, J.J., IDIOATE, M., SOBER, A.J., SEIZINGER, B.R. and BARNHILL, R.L., Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int. J. Cancer, 55, 562-565 (1993).
5. CESARMAN, E., INGHIRAMI, G., CHADBURN, A. and KNOWLES, D.M., High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Amer. J. Pathol., 143, 845-856 (1993).
6. CHO, Y., GORINA, S., JEFFREY, P.D. and PAVLETICH, N.P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 265, 346-355 (1994).
7. CRISTOFOLINI, M., BOI, S., GIRLANDO, S., ZUMIANE, G., CRISTOFOLINI, P., DALLA PALMA, P., DOGLIONE, C. and BARBARESCHI, M., p53 protein expression in nevi and melanomas. Arch. Dermatol., 129, 739-743 (1993).
8. DOCKHORN-DWORNICZAK, B., YANDELL, D.W., MERRITT, V., BOECKER, W. and POREMBA, C., p53 mutation in primary malignant melanoma. Proc. Amer. Assoc. Cancer Res., 34, 111 (abstract) (1993).
9. FLØRENES, V.A., HOLM, R. and FODSTAD, Ø., Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome. Melanoma Res., 5, 183-187 (1995).
10. FLØRENES, V.A., ØYJORD, T., HOLM, R., SKREDE, M., BØRRESEN, A.L., NESLAND, J.M. and FODSTAD, Ø., TP53 allele loss, mutations and expression in malignant melanoma. Brit. J. Cancer, 69, 253-259 (1994).
11. HALL, P.A. and LANE, D.P., p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J. Pathol., 172, 1-4 (1994).
12. HALL, P.A., MCKEE, P.H., MENAGE, H.D., DOVER, R. and LANE, D.P., High levels of p53 protein in UV irradiated normal human skin. Oncogene, 8, 203-207 (1993).
13. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
14. HARTMANN, A., BLASZYK, H., CUNNINGHAM, J.S., MCGOVERN, R.M., SCHROEDER, J.S., HELANDER, S.D., PITTELKOW, M.R., SOMMER, S.S. and KOVACH, J.S., Overexpression and mutations of p53 in metastatic malignant melanomas. Int. J. Cancer, 67, 313-317 (1996).
15. LASSAM, N.J., FROM, L. AND KAHN, H.J., Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res., 53, 2235-2238 (1993).
16. LEVIN, D.B., WILSON, K., VALADARES DE AMORIM, G., WEBBER, J., KENNY, P. and KUSSER, W., Detection of p53 mutations in benign and dysplastic nevi. Cancer Res., 55, 4278-4282 (1995).
17. LEVINE, A.J., MOMAND, J. and FINLAY, C.A., The p53 tumor suppressor gene. Nature (Lond.), 51, 453-456 (1991).
18. LÜBBE, J., REICHEL, M., BURG, G. and KLEIHUES, P., Absence of p53 gene mutations in cutaneous melanoma. J. invest. Dermatol., 102, 819-821 (1994).
19. MCGREGOR, J.M., YU, C.C.W., DUBLIN, E.A., BARNES, D.M., LEVISON, D.A. and MACDONALD, D.M., p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Brit. J. Dermatol., 128, 606-611 (1993).
20. MOMAND, J., ZAMBETTI, G.P., OLSON, D.C., GEORGE, D. and LEVINE, A.J., The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245 (1992).
21. PAPP, T., JAFARI, M. and SCHIFFMANN, D., Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions. J. Cancer Res. clin. Oncol., 122, 541-548 (1996).
22. PERRY, M.E., PIETTE, J., ZAWADZKI, J.A., HARVEY, D. and LEVINE, A.J., The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. nat. Acad. Sci. (Wash.), 90, 11623-11627 (1993).
23. STRAUME, O. and AKSLEN, L.A., Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int. J. Cancer, 74, 535-540 (1997).
24. STRETCH, J.R., GATTER, K.C., RALFKIAER, E., LANE, D.P. and HARRIS, A., Expression of mutant p53 in melanoma. Cancer Res., 51, 5976-5979 (1991).
25. TENAUD, C., NEGOESCU, A., LABAT-MOLEUR, F., LEGROS, Y., SOUSSI, T. and BRAMBILLA, E., p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas. Mod. Pathol., 7, 853-859 (1994).
26. SPARROW, L.E., ENGLISH, D.R., HEENAN, P.J., DAWKINS, H.J. and TARAN, J., Prognostic significance of p53 over-expression in thin melanomas. Melanoma Res., 5, 387-392 (1995).
27. WEISS, J., HEINE, M., KORNER, B., PILCH, H. and JUNG, E.G., Expression of p53 protein in malignant melanoma: clinopathological and prognostic implications. Brit. J. Dermatol., 133, 23-31 (1995).
28. WEISS, J., SCHWECHHEIMER, K., CAVENEE, W.K., HERLYN, M. and ARDEN, K.C., Mutation and expression of the p53 gene in malignant melanoma cell lines. Int. J. Cancer, 54, 693-699 (1993).
29. YAMAMOTO, M., TAKAHASHI, H., SAITOH, K., HORIKOSHI, T. and TAKAHASHI, M., Expression of the p53 protein in malignant melanoma as a prognostic indicator. Arch. Dermatol. Res., 287, 146-151 (1995).
30. YOSHIMOTO, K., IWAHANA, H., FUKUDA, A., SANO, T., SAITO, S. and HAKURA, M., Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction single strand conformation polymorphism. Cancer Res., 52, 5061-5064 (1992).